Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Prostatic Neoplasms 3Breast Neoplasms 3Ovarian Neoplasms 2Triple Negative Breast Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neurologic Manifestations 1Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Graft vs Host Disease 1Colonic Neoplasms 1Carcinoma, Renal Cell 1COVID-19 1Brain Neoplasms 1

Interventions

Methotrexate 10Cyclophosphamide 8Cyclosporine 6Tacrolimus 4Mycophenolic Acid 4Sirolimus 3Antilymphocyte Serum 3fludarabine 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Pentostatin 2Methylprednisolone 2Cyclosporins 2Busulfan 2trihexyltetradecylphosphonium chloride 1thymoglobulin 1ruxolitinib 1merphos 1ibrutinib 1fludarabine phosphate 1aldesleukin 1Whole-Body Irradiation 1Thiotepa 1Therapeutics 1Rituximab 1Proto-Oncogene Proteins c-raf 1Prednisone 1Photopheresis 1Methylprednisolone Hemisuccinate 1Methylprednisolone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Graft vs Host Disease × Atorvastatin × Clear all
NCT03066466 2021-04-27

Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT

Loyola University

Phase 3 Withdrawn
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡